Category "News"

OBaris is excited to share that we joined the Swiss National Startup Team! Represented by our CEO David Klein Cerrejon, we will be participating in a roadshow in Boston from May 13 to May 17, 2024, alongside nine other startups. The aim of the roadshow is to connect the participants with international investors and industry leaders, accelerating their ventures’ expansion in the US. Read the full announcement at Venture Leaders Biotech 2024: 10 innovative startups selected for the Boston roadshow – Venturelab.

The roadshow is organized by the Venturelab and you can check their programs and events at Venturelab – World-class Startups. Swiss made.

OBaris wins Stage III Venture Kick and receives additional CHF 100’000! Read the announcement and learn more about our Venture Kick experience at OBaris obtains the CHF 150,000 Kick to enable the painless delivery of injectable drugs (venturekick.ch)

Venture Kick is a philanthropic initiative with a three-stage funding model initiated to financially support Swiss startups to kick-start their entrepreneurial journey. Moreover, Venture Kick provides media exposure, credibility, kickers camps, and access to a broad network of industry experts and investors to the selected projects. Learn more about the Venture Kick at Venture Kick – CHF 150,000 to kick your startup.

OBaris receives CHF 150’000 for the accelerated market entry from Gebert Rüf Foundation!

As a part of their InnoBooster program, Gebert Rüf Foundation supports university-based, high-potential businesses from the Venture Kick program with the aim of substantially accelerating their market entry. Learn more about the foundation and their areas of activities at Home EN | Gebert Rüf Stiftung (grstiftung.ch).

Our co-founder David Klein Cerrejon pitched at Swiss Nordic Bio 2024 in the biotech section!

David and Nevena had exciting discussions with local and Nordic startups, pharmaceutical companies and investors.

Read more about the event at Swiss Nordic Bio.

Transire Bio represented by our co-founder David Klein Cerrejon, receives the Bridge Proof of Concept Fellowship! The BRIDGE funding program is a cooperation between Innosuisse – Swiss Innovation Agency and the SNSF Swiss National Science Foundation.

Story about Transire Bio featured in ftmedien! Read the complete article at Saugnäpfe statt Nadelstiche – ftmedien.ch Gesundheit.

Transire Bio receives additional CHF 40’000 and advances to the next stage of Venture Kick!

Venture Kick is a philanthropic initiative with a three-stage funding model initiated to financially support Swiss startups to kick-start their entrepreneurial journey. Moreover, Venture Kick provides media exposure, credibility, kickers camps, and access to a broad network of industry experts and investors to the selected projects.

Read the announcement at CHF 40,000 for technologies to uncover underground corrosion, restoration of soil health, and painless delivery of injectable drugs (venturekick.ch) and check our profile on their website Transire Bio – Venture Kick. Learn more about the Venture Kick at Venture Kick – CHF 150,000 to kick your startup.

Our main publication is out and ETH News published an exciting article covering our innovation and Transire Bio!

Read the full article at https://ethz.ch/en/news-and-events/eth-news/news/2023/09/how-a-suction-cup-delivers-medications-to-the-bloodstream.html?utm_source=linkedin&utm_medium=ETH+Z%C3%BCrich&utm_content=9f726d3d48014c3fb595fc0e1f853557-4923&utm_campaign=HK_Grund_Forschung.